Ah … the infamous work contact! As a pharmaceutical representative, and then as a district sales manager in the late '80s, I became intimately familiar with the practice of riding with your manager from both the passenger's and the driver's sides of the car.
Ah ⦠the infamous work contact! As a pharmaceutical representative, and then as a district sales manager in the late '80s, I became intimately familiar with the practice of riding with your manager from both the passenger's and the driver's sides of the car.
In preparation for writing this article, I went back through some old files and memos that I'd sent to my district when work contacts were a way of life for me. I recalled writing a memo on the subject and wondered if its content would still be appropriate today.
While the demands on - and pressures facing - pharmaceutical consultants have grown over the last decade with the advent of managed care and significant field force expansions, I found that the content of my work contact memo (shown here on the right) was still relevant. I am confident that your managers will agree.
It is also important to remember to be at your personal best when your manager or someone from the home office rides with you. Be considerate. Keep your car clean and organized â both inside and out.
A rep's trunk can speak volumes as to how a day, week and territory are managed. If you do not have a plan of action and priorities established when your boss is with you, what must things look like when you're alone?
Work contacts are essential for your professional growth and for maximizing your effectiveness in your territory. So get your clinical trials in order, set the right objectives for the right MDs and other decision makers, and understand and execute national strategy with passion and purpose.
Before you know it, you too may be sitting on the passenger side of the car for your next work contact! PR
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.